Sun Pharma starts Phase II trial of SCD-044 for moderate to severe plaque psoriasis
SCD-044 is also being evaluated in other autoimmune disorders and Phase 2 studies for other indications like atopic dermatitis,…
Sign in / Join
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Sun Pharma
Browsing Tag
Sun Pharma
Himachal Pradesh invites industry to sign MoU to set up units in proposed bulk drug park at Una
The State has identified 1,400 acres of land in Una for the bulk drug park and is promising competitive prices for land, power,…
Sun Pharma, Strides Pharma recall drugs in the US
Sun Pharma is recalling 747 bottles of generic diabetes drug due to higher levels of NDMA while Strides Pharma is recalling 11,280…
Marksans Pharma and Sun Pharma voluntarily recall metformin
oth the companies are recalling metformin because it may contain N-nitrosodimethylamine (NDMA) above the acceptable intake limit.
Sun Pharma launches ILUMYA (tildrakizumab) in Japan
It is indicated for the treatment of plaque psoriasis in adult patients who have an inadequate response to conventional therapies…
NPPA fixes retail prices of 30 formulations, rejects four applications
Two applications each of Micro Laboratories and Sun Pharma have been deferred by the authority
Lupin, Sun Pharma recall drugs in US market
Lupin is recalling 11,688 bottles of Lisinopril tablets USP, 10 mg while Sun Pharma is recalling 3,516 bottles of Clonazepam…
Sun Pharma arm to acquire Aquinox Pharmaceuticals (Canada)
The cost of acquisition is about $8.2 million
Aim to gain market share, preserve cash, reduce overall debt in times of COVID-19: Dilip Shanghvi
The company's focus is also on supply chain protection and ensuring optimum utilisation of its factories informed the MD of the…
Sun Pharma receives Japan MHLW approval of ILUMYATM for the treatment of Plaque Psoriasis
ILUMYA is one of the key specialty products of Sun Pharma and it was approved by US FDA in March 2018 while the European…
